Thyroid Cancer Rates Are Skyrocketing From Flame Retardants

By Dr. Mercola It’s estimated that nearly 57,000 new cases of thyroid cancer will be diagnosed in the U.S. in 2017, a far lower number than many other adult cancers, like colorectal, lung, breast and prostate.1 However, the number is noteworthy because it has risen significantly in recent years. Rates of thyroid cancer have tripled in the last decade, making it — papillary thyroid cancer in particular — the most rapidly increasing cancer in the U.S.2 While part of this rise is blamed on the increased use of thyroid ultrasound detecting small thyroid nodules that may otherwise have gone undiagnosed, environmental factors may also be playing a role. In fact, a study published in JAMA in March 2017 revealed that the overall incidence of thyroid cancer increased 3 percent annually in the U.S. from 1974 to 2013, representing a true increase.3 Dr. Julie Ann Sosa, chief of endocrine surgery at Duke University Medical Center in North Carolina, led a recent study on the topic, which sugg
http://articles.mercola.com/sites/articles/archive/2017/04/18/thyroid-cancer-linked-to-flame-retardant-exposure.aspx